May 2007
Volume 48, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2007
Ahmed Glaucoma Implant for Control of Refractory Glaucoma Following Penetrating Keratoplasty. A Challenging Management Venue
Author Affiliations & Notes
  • N. M. Radcliffe
    Ophthalmology, New York University, New York, New York
    Ophthalmology, Manhattan Eye, Ear and Throat Hospital, New York, New York
  • H. D. Perry
    Ophthalmology, Ophthalmic Consultants of Long Island, Lynbrook, New York
  • A. J. Kanellopoulos
    Ophthalmology, New York University, New York, New York
    Ophthalmology, Manhattan Eye, Ear and Throat Hospital, New York, New York
  • Footnotes
    Commercial Relationships N.M. Radcliffe, None; H.D. Perry, None; A.J. Kanellopoulos, None.
  • Footnotes
    Support None.
Investigative Ophthalmology & Visual Science May 2007, Vol.48, 4671. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      N. M. Radcliffe, H. D. Perry, A. J. Kanellopoulos; Ahmed Glaucoma Implant for Control of Refractory Glaucoma Following Penetrating Keratoplasty. A Challenging Management Venue. Invest. Ophthalmol. Vis. Sci. 2007;48(13):4671.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose:: To describe results of treating severe post-keratoplasty glaucoma with the ahmed glaucoma implant model S3.

Methods:: Noncomparative interventional case series.

Results:: Twenty-five patients (27 eyes) underwent implantation of an Ahmed glaucoma implant (model S3) for medically uncontrollable intraocular pressures (IOPs) after penetrating keratoplasty. Most of the eyes had pre-existing glaucoma, and 22 of 27 (81%) were pseudophakic following keratoplasty. Other glaucoma procedures had been performed previously on eleven eyes (40%): diode laser trabeculoplasty (five eyes), trabeculectomy (seven eyes), trans-scleral diode laser cyclophotocoagulation (three eyes), and cyclo-cryotherapy (two eyes). One eye in an aphakic patient required placement of two shunts. Follow-up ranged from 11 to 56 months (mean: 19 months). Two eyes developed phthisis bulbi. Three eyes required repeat keratoplasty, four required lysis of vitreous bands from tube ostia by YAG laser, and three underwent additional pars plana vitrectomy. Mean IOP changed from 26.5 pre-op on minimum 2 topical medications, to 16.5 post-op on minimum one topical medication. No repeat implants were required with the exception of one valve revision 2 months following implantation. Corneal allograft failure occurred in five eyes (20%). Including the re-grafted eyes, 21 eyes (78%) had clear grafts and controlled IOPs at the most recent postoperative examination.

Conclusions:: Overall, maintaining graft clarity and intraocular pressure control in eyes with refractory glaucoma after keratoplasty is challenging. However, the Ahmed S3 implant may prove useful in the management of otherwise uncontrollable glaucoma following penetrating keratoplasty.

Keywords: cornea: clinical science • transplantation • intraocular pressure 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×